The Equistasi® project stems from advanced technical-scientific research that started back in 1996, based on experimental applications in the fields of theoretical and applied nanotechnology.
Equistasi® is a wearable and innovative medical device, approved by the Ministry of Health on 05-08-2010 with CNN product code number 342575 and COP product code number 342577. It is based on vibrational technology: it self-generates focal mechanical vibrations at a non-constant frequency of about 9000 Hz, within the limits imposed by Legislative Decree 81/08.
Equistasi® has characteristics that make it, to date, a highly innovative tool:
a) It’s wearable: this device is applied like you would a regular bandage strip during daily motor activities with total independence or during the rehabilitation treatment carried out by a physiotherapist or professional in the sector.
b) It’s lightweight: this device is 1×2 cm in size and has a feather-light weight of only 0.17 grams.
c) It’s multi-applicable: this device can be reused several times and in different areas for different issues, depending on the instructions of the therapist or doctor.
d) It will not expire: other than general wear, this device will never expire.
Equistasi® is composed exclusively of applied nanotechnology fibres and does not contain any pharmacological elements. It provides support for the patient’s rehabilitative therapy.
Focal mechanical vibration applied on the affected muscular areas interacts with the mechanoreceptors, the Golgi tendon organs and the neuromuscular spindles. The stimuli generated by the vibrations transmit the information to the central nervous system. Stimulated by the vibrations, the higher motor centres improve the proprioceptive information that underlies motor control.
For these reasons, the application of Equistasi® proves to be an innovative and particularly interesting rehabilitative therapy.
Physiotherapists play a fundamental role in innovative rehabilitation; they must possess multidisciplinary knowledge in biomechanics, anatomy, physiology and neurophysiology and must be ready to predict the effects of the interaction between the Equistasi® device and the anatomical areas involved in the process.